Mesoangioblasts of inclusion-body myositis: A twofold tool to study pathogenic mechanisms and enhance defective muscle regeneration

Acta Myologica

Volumn 30, Issue JUNE, 2011, Pages 24-28

  Morosetti, Roberta ^a,b   Gliubizzi, C ^a,b   Broccolini, A ^a,b   Sancricca, C ^a,b   Mirabella, Massimiliano ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Inclusion body myositis; Mesoangioblasts; Muscle regeneration; Myogenic stem cells

Indexed keywords

CYTOKINE; GROWTH FACTOR;

CELL DIFFERENTIATION; HEMANGIOBLAST; HUMAN; INCLUSION BODY MYOSITIS; INFLAMMATORY CELL; MESOANGIOBLAST; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; PATHOGENESIS; REVIEW; SKELETAL MUSCLE;

ANIMALS; CELL DIFFERENTIATION; HUMANS; MESODERM; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; REGENERATION; STEM CELLS;

EID: 79958046988     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Torrente Y, Belicchi M, Sampaolesi M, et al. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 2004;114:182-95. (Pubitemid 39071623)
2. Torrente Y, Camirand G, Pisati F, et al. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J Cell Biol 2003;162:511-20. (Pubitemid 36988559)
3. Camargo FD, Green R, Capetanaki Y, et al. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med 2003;9:1520-7. (Pubitemid 38004780)
4. Tamaki T, Akatsuka A, Ando K, et al. Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 2002;157:571-7. (Pubitemid 34839786)
5. Cossu G, Sampaolesi M. New therapies for muscular dystrophy: cautious optimism. Trends Molecular Medicine 2004;10:516-20. (Pubitemid 39303625)
6. Minasi MG, Riminucci M, De Angelis L, et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 2002;129:2773-83. (Pubitemid 34874259)
7. Cossu G, Bianco P. Mesoangioblasts - vascular progenitors for extravascular mesodermal tissues. Curr Opin Genet Dev 2003;13:537-42. (Pubitemid 37204932)
8. Sampaolesi M, Torrente Y, Innocenzi A, et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003;301:487-92. (Pubitemid 36900300)
9. Sampaolesi M, Blot S, D'Antona G, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006;444:574-9. (Pubitemid 44864430)
10. Morosetti R, Mirabella M, Gliubizzi C, et al. MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Proc Natl Acad Sci U S A 2006;103:16995-7000. (Pubitemid 44737366)
11. Dellavalle A, Sampaolesi M, Tonlorenzi R, et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 2007;9:255-67. (Pubitemid 46349927)
12. Morosetti R, Mirabella M, Gliubizzi C, et al. Isolation andcharacterization of mesoangioblasts from facioscapulohumeral muscular dystrophymuscle biopsies. Stem Cells 2007;25:3173-82. (Pubitemid 350294443)
13. McFerrin J, Engel WK, Askanas V. Cultured inclusion-body myositis muscle fibers do not accumulate beta-amyloid precursor protein and can be innervated. Neurology 1999;53:2184-7.
14. Morosetti R, Broccolini A, Sancricca C, et al. Increased aging in primary muscle cultures of sporadicinclusion-body myositis. Neurobiol Aging 2010;31:1205-14.
15. Massague J, Cheifetz S, Endo T, et al. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci U S A 1986;83:8206-10. (Pubitemid 17182470)
16. Polesskaya A, Seale P, Rudnicki MA. Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell 2003;113:841-52. (Pubitemid 36792029)
17. Azmi S, Ozog A, Taneja R. Sharp-1/DEC2 inhibits skeletal muscle differentiation through repression of myogenic transcription factors. J Biol Chem 2004;279:52643-52. (Pubitemid 39656640)
18. Galvez BG, Sampaolesi M, Brunelli S, et al. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol 2006;174:231-43. (Pubitemid 44079858)
19. Askanas V, Engel WK, Mirabella M/ Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis. Curr Opin Neurol 1994;7:448-56.
20. Iezzi S, Cossu G, Nervi C, et al. Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. Proc Natl Acad Sci U S A 2002;99:7757-62. (Pubitemid 34568764)
21. Palacios D, Puri PL. The epigenetic network regulating muscle development and regeneration. J Cell Physiol 2006;207:1-11.
22. Bryan BA, Li D, Wu X, et al. The Rho family of small GTPases: crucial regulators of skeletal myogenesis. Cell Mol Life Sci 2005;62:1547-55. (Pubitemid 41021578)
23. Bryan BA, Mitchell DC, Zhao L, et al. Modulation of muscle regeneration, myogenesis, and adipogenesis by the Rho family guanine nucleotide exchange factor GEFT. Mol Cell Biol 2005;25:11089-101. (Pubitemid 41747149)
24. Charrasse S, Meriane M, Comunale F, et al. N-cadherin-dependent cell-cell contact regulates Rho GTPases and beta-catenin localization in mouse C2C12 myoblasts. J Cell Biol 2002;158:953-65. (Pubitemid 35001085)
25. Charrasse S, Comunale F, Fortier M, et al. M-cadherin activates Rac1 GTPase through the Rho-GEF trio during myoblast fusion. MolBiol Cell 2007;18:1734-43. (Pubitemid 46717555)
26. Tedesco FS, Dellavalle A, Diaz-Manera J, et al. Repairingskeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin-Invest 2010;120:11-9.